Authorized purpose: Ventripoint VMS+ 4.0 is an adjunct to an existing ultrasound system that records, analyzes, stores, and retrieves digital ultrasound images for computerized three-dimensional analysis where cardiac-chamber volumes or ejection fractions are warranted or desired.
Clinical role
Diagnostic ultrasound acquisition, measurement, analysis, and professional review support.
Images and patients
Ultrasound · Left ventricle, right ventricle, left atrium, and right atrium
Key limitation
Keep in mind: Probe, mode, anatomy, population, acoustic window, workflow, and optional-feature limits vary by exact system and release.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Ventripoint VMS+ 4.0 is an adjunct to an existing ultrasound system that records, analyzes, stores, and retrieves digital ultrasound images for computerized three-dimensional analysis where cardiac-chamber volumes or ejection fractions are warranted or desired.
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Left ventricle, right ventricle, left atrium, and right atrium Input: Ultrasound acquisitions from supported probes, modes, presets, patient populations, and release-specific configurations.
Who uses it?Intended users: Qualified physicians, sonographers, and other appropriately trained ultrasound professionals.
What does the software produce?Output: Ultrasound image series, flow data, measurements, calculations, overlays, or reports for professional review.
What is its most important limitation?Key limitation: Probe, mode, anatomy, population, acoustic window, workflow, and optional-feature limits vary by exact system and release.
Clinical takeaway. Clinical role: Ventripoint VMS+ 4.0 is an adjunct to an existing ultrasound system that records, analyzes, stores, and retrieves digital ultrasound images for computerized three-dimensional analysis where cardiac-chamber volumes or ejection fractions are warranted or desired.
Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports bench testing, software verification and validation, electrical safety and EMC testing, and an internal user validation study on 160 ultrasound images of the right ventricle estimating the proportion of images with all anatomical points finalized by the user within the expert consensus region; test criteria were met and user performance with VMS+ 4.0 was at least as good as the predicate. The study did not evaluate accuracy of the initial AI-placed points. Results are as reported in the FDA submission, not independent validation.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Ventripoint VMS+ 4.0 is an adjunct to an existing ultrasound system that records, analyzes, stores, and retrieves digital ultrasound images for computerized three-dimensional analysis where cardiac-chamber volumes or ejection fractions are warranted or desired.
The exact FDA document reports bench testing, software verification and validation, electrical safety and EMC testing, and an internal user validation study on 160 ultrasound images of the right ventricle estimating the proportion of images with all anatomical points finalized by the user within the expert consensus region; test criteria were met and user performance with VMS+ 4.0 was at least as good as the predicate. The study did not evaluate accuracy of the initial AI-placed points. Results are as reported in the FDA submission, not independent validation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "Performance bench testing of the modified device was completed to verify that the modified device was substantially equivalent in performance specifications to the previously cleared device." … "Software verification and validation testing were conducted, and documentation was provides as recommended by". Read from the exact FDA decision document on 2026-11-14.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The exact FDA document reports bench testing, software verification and validation, electrical safety and EMC testing, and an internal user validation study on 160 ultrasound images of the right ventricle estimating the proportion of images with all anatomical points finalized by the user within the expert consensus region; test criteria were met and user performance with VMS+ 4.0 was at least as good as the predicate. The study did not evaluate accuracy of the initial AI-placed points. Results are as reported in the FDA submission, not independent validation.
FDA source
Exact FDA submission
Checked 2026-11-14
Packet wording: "Performance bench testing of the modified device was completed to verify that the modified device was substantially equivalent in performance specifications to the previously cleared device." … "Software verification and validation testing were conducted, and documentation was provides as recommended by". Read from the exact FDA decision document on 2026-11-14.
No exact submission-linked sensitivity endpoint with a verified population, threshold, tested version, and source was promoted.
Reported specificity
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No exact submission-linked specificity endpoint with a verified population, threshold, tested version, and source was promoted.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K241222 FDA evidence package for Ventripoint Medical System Plus (VMS+) 4.0
DesignFDA 510(k) decision evidence package reviewed for exact submission identity and labeled scope
PopulationLabeled population and configuration described in the K241222 FDA decision material
Scopeexact submission
Tested versionVentripoint VMS+ 4.0 configuration described in K241222
IndependenceSponsor or vendor study
K241222
Manufacturer evidence submitted for the exact FDA decision. It is not independent clinical validation, and local technical, clinical, privacy, security, and workflow acceptance remains necessary.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K241222 by exact native submission identifier. This does not exclude product-family, later, or adverse-event information.
Public source
Exact FDA submission
Checked 2026-09-04
Exact-identifier review does not prove absence of all product-family safety signals.
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging, procedural, or surgical service line and verify payer, site-of-service, and coding assumptions independently.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Ultrasound acquisitions from supported probes, modes, presets, patient populations, and release-specific configurations.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The exact FDA package describes VMS+ 4.0 software that can be installed on a separate workstation to import 3D datasets, MRI studies, and VMS+ studies, and its comparison table lists original VMS+ and DICOM image data formats. Interface versions and local compatibility require confirmation.
Scope: Exact FDA submission. Packet wording: "The software can also be installed on a separate workstation to import 3D datasets, MRI studies, and VMS+ studies." … "Image data format Original VMS+ and Original VMS+ and Same DICOM format DICOM format". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The exact FDA package describes a VMS+ system that includes a hardware stand with a computer, position sensors, and software for image capture, and states the software can also be installed on a separate workstation. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "The VMS+ system includes a hardware stand with a computer, position sensors to track the 3D orientation of the ultrasound transducer and patient movement, and software to handle image capture" … "The software can also be installed on a separate workstation to import 3D datasets, MRI studies, and VMS+ studies.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Unresolved route: Ultrasound image series, flow data, measurements, calculations, overlays, or reports for professional review.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes a VMS+ system that includes a hardware stand with a computer, position sensors, and software for image capture, and states the software can also be installed on a separate workstation. Current hosting, data flow, and commercial configuration require vendor confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "The VMS+ system includes a hardware stand with a computer, position sensors to track the 3D orientation of the ultrasound transducer and patient movement, and software to handle image capture" … "The software can also be installed on a separate workstation to import 3D datasets, MRI studies, and VMS+ studies.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
The exact FDA package describes VMS+ 4.0 software that can be installed on a separate workstation to import 3D datasets, MRI studies, and VMS+ studies, and its comparison table lists original VMS+ and DICOM image data formats. Interface versions and local compatibility require confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "The software can also be installed on a separate workstation to import 3D datasets, MRI studies, and VMS+ studies." … "Image data format Original VMS+ and Original VMS+ and Same DICOM format DICOM format". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Only qualified physicians, sonographers, and other appropriately trained ultrasound professionals should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Exact public integration details remain incomplete; establish and test the supported input, output, identity, routing, archive, report, and downtime contract locally.
exact submission · checked 2026-09-04
Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.
Use a signed local test set for the exact labeled population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Probe, mode, anatomy, population, acoustic window, workflow, and optional-feature limits vary by exact system and release.
exact submission · checked 2026-09-04
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-04
No exact-product price was found in reviewed public material; productivity or value claims require local evidence.
Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates.
exact submission · checked 2026-09-04
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. No exact native-submission recall record was found in the checked snapshot; this does not exclude other product-family or later signals.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
27Fields reviewed
12Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission
No public list price for the exact cleared configuration was found. Obtain a written quote separating license or hardware basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not publicly available - checked 2026-09-04 - Exact FDA submission
Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
Installation timeline: Not yet reviewed
Monitoring: Not publicly available - checked 2026-09-04 - Exact FDA submission
The exact FDA decision and checked recall snapshot do not establish a complete local postmarket monitoring protocol. Track version, population, anatomy, protocol, input quality, edits, failures, repeats, downstream effects, downtime, incidents, recalls, and updates locally.
Authorized purpose: VMS+ 3.0 is an adjunct to existing ultrasound imaging systems intended to record, analyze, store, and retrieve digital ultrasound images for computerized three-dimensional image processing. It is indicated where left-ventricle, right-ventricle, left-atrium, and right-atrium volumes and ejection fractions are warranted or desired.
Modality
Ultrasound
Anatomy
Left ventricle, right ventricle, left atrium, and right atrium
Authorized purpose: VMS+ is an adjunct to existing ultrasound imaging systems intended to record, analyze, store, and retrieve digital ultrasound images for computerized three-dimensional image processing. It is indicated where left-ventricle, right-ventricle, left-atrium, and right-atrium volumes and ejection fractions are warranted or desired.
Modality
Ultrasound
Anatomy
Left ventricle, right ventricle, left atrium, and right atrium
Authorized purpose: Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric, musculoskeletal, ophthalmic, urologic, vascular, small-organ, and lung examinations.
Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.